These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30863034)

  • 21. Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.
    Mella JM; Perret MC; Manzotti M; Catalano HN; Guyatt G
    Arch Dermatol; 2010 Oct; 146(10):1141-50. PubMed ID: 20956649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.
    Dhurat R; Sharma A; Rudnicka L; Kroumpouzos G; Kassir M; Galadari H; Wollina U; Lotti T; Golubovic M; Binic I; Grabbe S; Goldust M
    Dermatol Ther; 2020 May; 33(3):e13379. PubMed ID: 32279398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials.
    Zhou Z; Cui Y; Wu J; Jin H
    Exp Ther Med; 2020 Aug; 20(2):1566-1574. PubMed ID: 32742388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
    Tanglertsampan C
    J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
    Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
    Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
    Gupta AK; Talukder M; Shemer A
    Expert Opin Pharmacother; 2024 Feb; 25(2):139-147. PubMed ID: 38315101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system.
    Shin JW; Chung EH; Kim MB; Kim TO; Kim WI; Huh CH
    J Dermatol; 2019 Feb; 46(2):139-143. PubMed ID: 30536893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexual Problems of Men With Androgenic Alopecia Treated With 5-Alpha Reductase Inhibitors.
    Coskuner ER; Ozkan B; Culha MG
    Sex Med Rev; 2019 Apr; 7(2):277-282. PubMed ID: 30301703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo.
    Olsen EA; Whiting DA; Savin R; Rodgers A; Johnson-Levonas AO; Round E; Rotonda J; Kaufman KD;
    J Am Acad Dermatol; 2012 Sep; 67(3):379-86. PubMed ID: 22325459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and safety of oral dutasteride for male androgenetic alopecia in real clinical practice: A descriptive monocentric study.
    Vañó-Galván S; Saceda-Corralo D; Moreno-Arrones OM; Rodrigues-Barata R; Morales C; Gil-Redondo R; Bernárdez-Guerra C; Hermosa-Gelbard Á; Jaén-Olasolo P
    Dermatol Ther; 2020 Jan; 33(1):e13182. PubMed ID: 31820540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the therapeutic effects of AGA drugs by measuring finasteride, dutasteride, and dihydrotestosterone in hair.
    Hobo Y; Nishikawa J; Taniguchi Asai N; Yoneyama K; Watanabe Y; Miyashiro Y; Fujikata A
    Clin Chim Acta; 2023 Jul; 547():117456. PubMed ID: 37385468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.
    Iamsumang W; Leerunyakul K; Suchonwanit P
    Drug Des Devel Ther; 2020; 14():951-959. PubMed ID: 32184564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH; Roberts JL; Hordinsky M; Olsen EA; Savin R; Bergfeld W; Fiedler V; Lucky A; Whiting DA; Pappas F; Culbertson J; Kotey P; Meehan A; Waldstreicher J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis.
    Li Y; Ma J; Qin XH; Hu CY
    Transl Androl Urol; 2022 Mar; 11(3):313-324. PubMed ID: 35402192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia.
    Tsai TF; Choi GS; Kim BJ; Kim MB; Ng CF; Kochhar P; Jasper S; Brotherton B; Orban B; Lulic Z
    J Dermatol; 2018 Jul; 45(7):799-804. PubMed ID: 29667763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What's New in Therapy for Male Androgenetic Alopecia?
    Saceda-Corralo D; Domínguez-Santas M; Vañó-Galván S; Grimalt R
    Am J Clin Dermatol; 2023 Jan; 24(1):15-24. PubMed ID: 36169916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.